Literature DB >> 29164215

Controlling miRNA-like off-target effects of an siRNA with nucleobase modifications.

Scott R Suter1, Alexi Ball-Jones, Madeline M Mumbleau, Rachel Valenzuela, Jose Ibarra-Soza, Hassan Owens, Andrew J Fisher, Peter A Beal.   

Abstract

SiRNAs can cause unintended gene silencing due to miRNA-like effects because of the similarity in function of an siRNA guide strand and a miRNA. Here we evaluate the effect on miRNA-like off targeting of introducing the adenosine derivative 7-EAA and triazoles prepared from 7-EAA at different positions in an siRNA guide strand. We find that a sterically demanding triazole placed in the RNA duplex major groove at position six of the guide strand dramatically reduces miRNA-like off targeting potency. A high-resolution structure of an RNA duplex bearing a novel, major-groove localized triazole is reported, which suggests that modified triazoles could be disrupting the hAgo2-guide-target RNA ternary complex. Five different triazole modifications were tested at the guide strand 6-position for effects on on-target and miRNA-like off target knockdown potency. A 7-EAA triazole bearing a benzylamine substituent displayed on-target knockdown activity as potent as the native siRNA, while having an IC50 against a miRNA-like off target >100-fold higher. Melting temperature studies revealed no obvious correlation between potency in knockdown assays and a modification's effect on duplex stability. These results, along with known structures of hAgo2-guide-target ternary complexes, are used to rationalize the effect of 7-EAA triazoles on miRNA-like off target effects.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29164215      PMCID: PMC5734094          DOI: 10.1039/c7ob02654d

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  30 in total

1.  Widespread siRNA "off-target" transcript silencing mediated by seed region sequence complementarity.

Authors:  Aimee L Jackson; Julja Burchard; Janell Schelter; B Nelson Chau; Michele Cleary; Lee Lim; Peter S Linsley
Journal:  RNA       Date:  2006-05-08       Impact factor: 4.942

2.  Probing the active site of a diels-alderase ribozyme by photoaffinity cross-linking.

Authors:  Richard Wombacher; Andres Jäschke
Journal:  J Am Chem Soc       Date:  2008-06-11       Impact factor: 15.419

3.  Modified siRNA structure with a single nucleotide bulge overcomes conventional siRNA-mediated off-target silencing.

Authors:  Pooja Dua; Jae Wook Yoo; Soyoun Kim; Dong-ki Lee
Journal:  Mol Ther       Date:  2011-06-14       Impact factor: 11.454

4.  Structural basis for microRNA targeting.

Authors:  Nicole T Schirle; Jessica Sheu-Gruttadauria; Ian J MacRae
Journal:  Science       Date:  2014-10-31       Impact factor: 47.728

5.  7-Substituted 8-aza-7-deazaadenosines for modification of the siRNA major groove.

Authors:  José M Ibarra-Soza; Alexi A Morris; Prasanna Jayalath; Hayden Peacock; Wayne E Conrad; Michael B Donald; Mark J Kurth; Peter A Beal
Journal:  Org Biomol Chem       Date:  2012-07-05       Impact factor: 3.876

6.  Structure-Guided Control of siRNA Off-Target Effects.

Authors:  Scott R Suter; Jessica Sheu-Gruttadauria; Nicole T Schirle; Rachel Valenzuela; Alexi A Ball-Jones; Kazumitsu Onizuka; Ian J MacRae; Peter A Beal
Journal:  J Am Chem Soc       Date:  2016-07-12       Impact factor: 15.419

7.  How good are my data and what is the resolution?

Authors:  Philip R Evans; Garib N Murshudov
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2013-06-13

8.  A screen of chemical modifications identifies position-specific modification by UNA to most potently reduce siRNA off-target effects.

Authors:  Jesper B Bramsen; Malgorzata M Pakula; Thomas B Hansen; Claus Bus; Niels Langkjær; Dalibor Odadzic; Romualdas Smicius; Suzy L Wengel; Jyoti Chattopadhyaya; Joachim W Engels; Piet Herdewijn; Jesper Wengel; Jørgen Kjems
Journal:  Nucleic Acids Res       Date:  2010-05-07       Impact factor: 16.971

9.  Click modification of RNA at adenosine: structure and reactivity of 7-ethynyl- and 7-triazolyl-8-aza-7-deazaadenosine in RNA.

Authors:  Kelly J Phelps; José M Ibarra-Soza; Kiet Tran; Andrew J Fisher; Peter A Beal
Journal:  ACS Chem Biol       Date:  2014-06-16       Impact factor: 5.100

10.  Abasic pivot substitution harnesses target specificity of RNA interference.

Authors:  Hye-Sook Lee; Heeyoung Seok; Dong Ha Lee; Juyoung Ham; Wooje Lee; Emilia Moonkyung Youm; Jin Seon Yoo; Yong-Seung Lee; Eun-Sook Jang; Sung Wook Chi
Journal:  Nat Commun       Date:  2015-12-18       Impact factor: 14.919

View more
  10 in total

Review 1.  Strategies, design, and chemistry in siRNA delivery systems.

Authors:  Yizhou Dong; Daniel J Siegwart; Daniel G Anderson
Journal:  Adv Drug Deliv Rev       Date:  2019-05-15       Impact factor: 15.470

Review 2.  Emerging roles of non-coding RNAs in the pathogenesis, diagnosis and prognosis of osteosarcoma.

Authors:  Chongchong Wang; Juehua Jing; Li Cheng
Journal:  Invest New Drugs       Date:  2018-08-06       Impact factor: 3.850

3.  Challenges identifying efficacious miRNA therapeutics for cancer.

Authors:  Meirav Segal; Frank J Slack
Journal:  Expert Opin Drug Discov       Date:  2020-05-18       Impact factor: 6.098

Review 4.  Cervical cancer development, chemoresistance, and therapy: a snapshot of involvement of microRNA.

Authors:  Tandrima Mitra; Selvakumar Elangovan
Journal:  Mol Cell Biochem       Date:  2021-08-28       Impact factor: 3.396

5.  Partial DNA-guided Cas9 enables genome editing with reduced off-target activity.

Authors:  Hao Yin; Chun-Qing Song; Sneha Suresh; Suet-Yan Kwan; Qiongqiong Wu; Stephen Walsh; Junmei Ding; Roman L Bogorad; Lihua Julie Zhu; Scot A Wolfe; Victor Koteliansky; Wen Xue; Robert Langer; Daniel G Anderson
Journal:  Nat Chem Biol       Date:  2018-01-29       Impact factor: 15.040

Review 6.  Small interfering RNAs (siRNAs) in cancer therapy: a nano-based approach.

Authors:  Ghanbar Mahmoodi Chalbatani; Hassan Dana; Elahe Gharagouzloo; Santiago Grijalvo; Ramon Eritja; Craig D Logsdon; Fereidoon Memari; Seyed Rouhollah Miri; Mahdi Rezvani Rad; Vahid Marmari
Journal:  Int J Nanomedicine       Date:  2019-05-02

Review 7.  miRNA therapeutics in precision oncology: a natural premium to nurture.

Authors:  Chakresh Kumar Jain; Poornima Srivastava; Amit Kumar Pandey; Nisha Singh; R Suresh Kumar
Journal:  Explor Target Antitumor Ther       Date:  2022-08-31

Review 8.  Encapsulation of miRNA and siRNA into Nanomaterials for Cancer Therapeutics.

Authors:  Mina Zare; Rakesh Pemmada; Maya Madhavan; Aswathy Shailaja; Seeram Ramakrishna; Sumodan Padikkala Kandiyil; James M Donahue; Vinoy Thomas
Journal:  Pharmaceutics       Date:  2022-08-03       Impact factor: 6.525

9.  Exploring PAZ/3'-overhang interaction to improve siRNA specificity. A combined experimental and modeling study.

Authors:  Adele Alagia; Andreia F Jorge; Anna Aviñó; Tânia F G G Cova; Ramon Crehuet; Santiago Grijalvo; Alberto A C C Pais; Ramon Eritja
Journal:  Chem Sci       Date:  2018-01-15       Impact factor: 9.825

Review 10.  Recent advances in siRNA delivery mediated by lipid-based nanoparticles.

Authors:  Sei Yonezawa; Hiroyuki Koide; Tomohiro Asai
Journal:  Adv Drug Deliv Rev       Date:  2020-08-06       Impact factor: 15.470

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.